For review by noon Monday 7/15: Review draft NIAID TA on Risky Research Review Act
Reading Room Production, pp.114-115 · reading_room:email:00119
Page text: p.114, p.115 · original PDF
- Date
- 2024-07-15 10:35
- Type
- email · email
- cc
- Emily Erbelding, Steven Holland, Christopher Hanson, Kelly Poe, Sharon Gilles, Ddsm Correspondences
- sender
- Sara Selgrade
- Topics
- Proximal Origin paper
This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.
This is a duplicate copy. Canonical version: reading_room:email:00127
Hello all,
ol
In the attached revised draft, I
jections, I will submit these to
D) (e)]
PM
AID DEA DART
NIAID) [E] i
\IH/NIAID) [E] ii
||
NIH/NIAID) [E]
NIAID) [E]
VIH/NIAID) [E] iy
>;
||
(NIH/NIAID) [E]
NIH/NIAID) [E] ay
NIAID) [E]
has asked us to
ze
We will be sure
Please let me know if you have any questions.
()
1AM
[AID DEA DART
ID DIR-OCGR <
VIH/NIAID) [--] i
I
Thank you for your quick review of the draft NIAID TA on the Risky Research Review Act. In the attached revised draft, I
have incorporated additional edits from DMID/Dr. Erbelding and DEA. If there are no objections, I will submit these to
NIH OLPA by their noon deadline today.
I am also attaching for your reference additional comments on the bill provided by NIH OER and NIH ORS/DOHS.
Please let me know if you have any questions or concerns.
Thanks,
Sara